“ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS”. Mediterranean Journal of Hematology and Infectious Diseases 4, no. 1 (November 6, 2012): e2012072. Accessed April 18, 2026. https://www.mjhid.org/mjhid/article/view/2012.072.